309 results
Page 8 of 16
8-K
EX-99.1
5t2ttb cak6fta2
12 Mar 13
BioTime Appoints Stephen C. Farrell to Board of Directors
12:00am
DEFA14A
EX-99.1
nnhanv3kutw
7 Mar 13
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
oeygtzb2wnjb7b5uoc
7 Mar 13
BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of $5 Million Financing
12:00am
8-K
EX-99.1
rhh0weydky 07ja
4 Mar 13
BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration
12:00am
8-K
EX-99.1
t3ueaztob
11 Feb 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ir7c4
31 Jan 13
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
rx16s
30 Jan 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
gquvztquutimxkueojl6
18 Jan 13
BioTime CEO Dr. Michael West to Present at Scale-Up and Manufacturing of Cell-Based Therapies II Conference
12:00am
8-K
EX-99.1
q1z8p pzu
10 Jan 13
BioTime Submits Protocol for Initiation of Human Clinical Trials of Renevia™ in Europe
12:00am
8-K
EX-99.1
wn5j7d4q2g
9 Jan 13
LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of MalaCards Version 1.02
12:00am
8-K
EX-99.1
k45r91anv56fwh6o
20 Dec 12
BioTime Announces the Appointment of Jeffrey Janus as Vice President
12:00am
8-K
EX-99.1
d6m4x70v
18 Dec 12
BioTime Reports Isolation of Seven Diverse Cartilage and Bone Cell Types From Human Embryonic Stem Cells
12:00am
8-K
EX-99.1
p0e2qh7h6i926
4 Dec 12
BioTime CEO Dr. Michael West Presents Product Development Update at World Stem Cell Summit 2012
12:00am
8-K
EX-99.1
jwzbdl rp5
29 Nov 12
BioTime CEO Dr. Michael West to Present at World Stem Cell Summit 2012
12:00am
8-K
EX-99.1
mqfz 6ypm
27 Nov 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ql4ex bt1bzdmgcva
20 Nov 12
LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution Agreement with ProSpec-Tany TechnoGene
12:00am
8-K
EX-99.1
w6i u3mr1z64dhl
19 Nov 12
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.09
12:00am
8-K
EX-99.2
idsp5spcw2 rct2
15 Nov 12
BioTime Announces Non-Binding Letter of Intent with Geron Regarding Stem Cell Assets
12:00am
8-K
EX-99.1
98d48 gnx9c
15 Nov 12
BioTime Announces Non-Binding Letter of Intent with Geron Regarding Stem Cell Assets
12:00am
8-K
EX-99.1
cbb3fmp n3sn9tw
7 Nov 12
BioTime and Subsidiary Cell Cure Neurosciences Ltd. Announce Financing
12:00am